Tuesday, June 26, 2012

Affymetrix completes $315 million eBioscience acquisition

Santa Clara-based Affymetrix (NASDAQ:AFFX) said the purchase price was about $315 million in cash, funded through a new senior secured credit facility, an offering of convertible notes and other cash resources. The price is lower than a previously announced $330 million.

No comments:

Post a Comment